Back to User profile » Dr Pedro Such
Papers published by Dr Pedro Such:
Brexpiprazole for Agitation in Patients with Alzheimer’s Dementia with and without Co-Occurring Psychosis: Post Hoc Analysis of Short- and Long-Term Trials
Tariot PN, Chumki SR, Wang D, Such P, Palma AM, Zhang Z, Montano CB
Neuropsychiatric Disease and Treatment 2026, 22:586701
Published Date: 21 April 2026
Exploring Patient, Caregiver, and Prescriber Preferences for an Injectable Antipsychotic Administered Every 2 Months for the Maintenance Treatment of Schizophrenia: A Multicenter Qualitative Interview Study Conducted in Europe
Pappa S, Yildirim M, Loomer S, Beckham C, Bates D, Micheelsen A, Harrsen K, Nag SS, Guillaume X, Oladini B, Madera-McDonough J, Such P
Patient Preference and Adherence 2025, 19:1179-1195
Published Date: 29 April 2025
Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison
Harlin M, Chepke C, Larsen F, Bell Lynum KS, Chumki SR, Fitzgerald H, Such P, Madera-McDonough J, Yildirim M, Panni M, Saklad SR
Neuropsychiatric Disease and Treatment 2023, 19:1409-1416
Published Date: 8 June 2023
Online Survey of Clinical Practice in Patients with Schizophrenia Treated with Long-Acting Injectable Aripiprazole or Paliperidone Palmitate
Such P, Olivares JM, Arias L, Troels Berg M, Madera J
Neuropsychiatric Disease and Treatment 2021, 17:1881-1892
Published Date: 10 June 2021
Use of the Functioning Assessment Short Test (FAST) in defining functional recovery in bipolar I disorder. Post-hoc analyses of long-term studies of aripiprazole once monthly as maintenance treatment
Madera J, Such P, Zhang P, Baker RA, Grande I
Neuropsychiatric Disease and Treatment 2019, 15:2325-2338
Published Date: 15 August 2019
The effect of aripiprazole once-monthly on personal and social functioning: post hoc analyses of acute and long-term studies
Peters-Strickland T, Baker RA, Such P, Zhang P, Madera JJ
Neuropsychiatric Disease and Treatment 2019, 15:1659-1669
Published Date: 24 June 2019
Symptomatic stability with aripiprazole once-monthly: efficacy analyses from acute and long-term studies
Madera JJ, Such P, Zhao C, Baker RA
Neuropsychiatric Disease and Treatment 2019, 15:1593-1604
Published Date: 18 June 2019
Quantifying the treatment goals of people recently diagnosed with schizophrenia using best–worst scaling
Bridges JFP, Beusterien K, Heres S, Such P, Sánchez-Covisa J, Nylander AG, Chan E, de Jong-Laird A
Patient Preference and Adherence 2018, 12:63-70
Published Date: 4 January 2018
Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
Salzman PM, Raoufinia A, Legacy S, Such P, Eramo A
Neuropsychiatric Disease and Treatment 2017, 13:1125-1129
Published Date: 20 April 2017